Selective immunosuppressants
Apremilast
The FDA lists this product in 42 strengths and forms.
Composition
- Active ingredients
- APREMILAST 30MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- APREMILAST 20MG · TabletANDA211756-002 · Discontinued
- APREMILAST 30MG · TabletANDA211756-003 · Discontinued
- APREMILAST 10MG · TabletANDA211756-001 · Discontinued
- APREMILAST 20MG · TabletANDA211782-002 · Discontinued
- APREMILAST 30MG · TabletANDA211782-003 · Discontinued
- APREMILAST 10MG · TabletANDA211782-001 · Discontinued
- APREMILAST 20MG · TabletANDA211859-002 · Tentative approval
- APREMILAST 30MG · TabletANDA211859-003 · Tentative approval
- APREMILAST 10MG · TabletANDA211859-001 · Tentative approval
- APREMILAST 20MG · TabletANDA211716-002 · Discontinued
- APREMILAST 30MG · TabletANDA211716-003 · Discontinued
- APREMILAST 10MG · TabletANDA211716-001 · Discontinued
- APREMILAST 30MG · TabletThis page
- APREMILAST 10MG · TabletANDA211887-001 · Prescription
At a glance
- Brand name
- Apremilast
- Drug class
- Selective immunosuppressants
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- MSN
- Status
- Prescription
- FDA approval
- 16 Dec 2024
- Application
- ANDA211887-003
- RxCUI
- 1492727